Cite
MLA Citation
Alexandre Bazinet et al.. “Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study.” Lancet, vol. 9, no. 10, 2022, pp. e756–e765. http://access.bl.uk/ark:/81055/vdc_100166747440.0x000008